Keith T. Flaherty, Director at Loxo Oncology, Inc. (LOXO), sold 14,500 shares at $30.23 ($438K) on 2016-12-19, disclosed to the SEC on 2016-12-21.
Open-market sale of $438k LOXO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.23 | 7,250 | $219K | 50.0% |
| 2 | $30.23 | 7,250 | $219K | 50.0% |
| Total | $30.23 avg | 14,500 | $438K | 100% |
| Filing → |
| LOXO | SELL | 2017-08-23 | $775K | — | Filing → |
| LOXO | SELL | 2017-05-24 | $649K | — | Filing → |
| LOXO | SELL | 2017-02-23 | $601K | — | Filing → |